Animal NDC 17033-501-01 Vetivex Veterinary Phylyte
Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride, And Magnesium Chloride
Animal Product Information
| Field Name | Field Value |
|---|---|
| Animal NDC Code | 17033-501-01 |
| Proprietary Name | Vetivex Veterinary Phylyte What is the Proprietary Name? The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes. |
| Non-Proprietary Name | Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride, And Magnesium Chloride What is the Non-Proprietary Name? The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product. |
| Labeler Name | Dechra Veterinary Products |
| Product Type | Prescription Animal Drug |
| Usage Information |
|
| Active Ingredient(s) |
|
| Inactive Ingredient(s) |
|
| Marketing Category | UNAPPROVED DRUG OTHER What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Vetivex Veterinary Phylyte Images
Vetivex Veterinary Phylyte Animal Product Labeling Information
The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.
Table of Contents
Other
For Animal Use Only
CAUTION: Federal law (USA) restricts this drug to use by or on the order of a licensed veterinarian.
Distributed by:
Dechra Veterinary Products
7015 College Boulevard, Suite 525,
Overland Park, KS 66211
| TAKE TIME | OBSERVE LABEL DIRECTIONS |
Made in El Salvador
For a copy of the Safety Data Sheet (SDS)
or to report adverse reactions call Dechra Veterinary Products at (866) 933-2472.
VETIVEX® and pHyLyte® are trademarks of Dechra, Ltd; all rights reserved.
© 2017 Dechra Ltd.
REV.10/17
Description:
Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) is a sterile, nonpyrogenic isotonic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. It contains no antimicrobial agents or preservatives. Discard unused portion. The pH is adjusted with sodium hydroxide.
| Size (mL) | Composition (mg/100mL) | Ionic Concentration (mEq/L) | kcal/L | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sodium Chloride, USP (NaCl) | Sodium Gluconate, USP (C6H11NaO7) | Sodium Acetate Trihydrate, USP (C2H3NaO2∙3H2O) | Potassium Chloride, USP (KCl) | Magnesium Chloride, USP (MgCl2∙6H2O) | Osmolarity (mOsmol/L) (calc) | pH | Sodium | Potassium | Magnesium | Chloride | Acetate | Gluconate | Caloric Content | |
| 1000 | 526 | 502 | 368 | 37 | 30 | 294 | 7.4 (6.5 to 8.0) | 140 | 5 | 3 | 98 | 27 | 23 | 21 |
| 3000 | ||||||||||||||
| 5000 | ||||||||||||||
Clinical Pharmacology:
Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) administered intravenously has value as a source of water and electrolytes. It is capable of inducing diuresis, depending on the clinical condition of the patient.
Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) produces a metabolic alkalinizing effect. Acetate and gluconate ions are metabolized ultimately to carbon dioxide and water, which requires the consumption of hydrogen cations.
Indications And Usage:
Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) is indicated as a source of water and electrolytes or as an alkalinizing agent.
Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) is compatible with blood or blood components. It may be administered prior to or following the infusion of blood through the same administration set (i.e. as a priming solution), added to or infused concurrently with blood components, or used as a diluent in the transfusion of packed erythrocytes. Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) and 0.9% Sodium Chloride Injection, USP are equally compatible with blood or blood components.
Contraindications:
None known.
Warnings:
Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there exists edema with sodium retention.
Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) should be used with great care, if at all, in patients with hyperkalemia, severe renal failure, and in conditions in which potassium retention is present.
Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) should be used with great care in patients with metabolic or respiratory alkalosis. The administration of acetate or gluconate ions should be done with great care in those conditions in which there is an increased level or an impaired utilization of these ions, such as severe hepatic insufficiency.
The intravenous administration of Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states, or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the injection. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injection.
In patients with diminished renal function, administration of Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) may result in sodium or potassium retention.
Adverse Reactions:
Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.
Precautions:
Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.
Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) should be used with caution. Excess administration may result in metabolic alkalosis.
Caution must be exercised in the administration of Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) to patients receiving corticosteroids or corticotropin.
Do not administer unless solution is clear and seal is intact.
Dosage And Administration
As directed by a veterinarian. Dosage is dependent upon the age, weight and clinical condition of the patient as well as laboratory determinations.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.
All injections in plastic containers are intended for intravenous administration using sterile equipment.
Additives may be incompatible. Complete information is not available. Those additives known to be incompatible should not be used. Consult with pharmacist, if available. If, in the informed judgment of the veterinarian, it is deemed advisable to introduce additives, use aseptic technique. Mix thoroughly when additives have been introduced. Do not store solutions containing additives. Discard unused portion.
Overdosage
In an event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. See Warnings, Precautions and Adverse Events.
How Supplied:
Veterinary pHyLyte® Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) in plastic container is available as follows:
| NDC Code | Volume |
|---|---|
| 17033-501-01 | 1000 mL PVC Free, DEHP Free and Latex Free Bag. |
| 17033-501-03 | 3000 mL The plastic container is fabricated from a specially formulated polyvinyl chloride. The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexyl phthalate (DEHP), up to 5 parts per million. However, the safety of the plastic has been confirmed in animals according to USP biological tests for plastic containers, as well as tissue culture toxicity studies. |
| 17033-501-05 | 5000 mL |
Storage:
Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored in the moisture barrier overwrap at room temperature (25°C/77°F); brief exposure up to 40°C/104°F does not adversely affect the product.
To Open
Tear overwrap down side at slit and remove solution container. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as sterility may be impaired.
If supplemental medication is desired, follow directions below.
Preparation For Administration
- Suspend container from eyelet support.
- Remove protector from outlet port at bottom of container.
- Attach administration set. Refer to complete directions accompanying set.
To Add Medication
WARNING: Additives may be incompatible.
Principal Display Panel - 1000 Ml Container Label
Vetivex®
Veterinary pHyLyte™ Injection pH 7.4
(Multiple Elecrolytes Injection, Type 1, USP)
STERILE - NONPYROGENIC SOLUTION
FOR ANIMAL USE ONLY
KEEP OUT OF REACH OF CHILDREN
CAUTION: FEDERAL LAW (U.S.A.) RESTRICTS THIS DRUG TO USE BY
OR ON THE ORDER OF A LICENSED VETERINARIAN.
NDC: 17033-501-01
1000 mL
Dechra
* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.